The Role of Acetylcysteine in Clinical Toxicology

  • R. J. Flanagan
Leading Article
  • 10 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmed AE, Trieff NM. Aliphatic nitrites: metabolism and toxicity. In Bridges & Chasseud (Eds) Progress in drug metabolism, Vol. 7, pp. 229–294, Wiley, Chichester, 1983Google Scholar
  2. Aposhian HV. DMSA and DMPS: water soluble antidotes tor heavy metal poisoning. Annual Review of Pharmacology and Toxicology 23: 193–215, 1983PubMedCrossRefGoogle Scholar
  3. Bateman DN, Woodhouse KW, Rawlins MD. Adverse reactions to N-acetylcysteine. Human Toxicology 3: 393–398, 1984PubMedCrossRefGoogle Scholar
  4. Bronstein AC, Linden CH, Hall AH, Kulig KW, Rumack BH, et al. Intravenous N-acetylcysteine for acute acetaminophen poisoning. Veterinary and Human Toxicology 27: 316, 1985Google Scholar
  5. Buchter A, Peter H, Bolt HM. N-acetyl-cysteine as an antidote in accidental acrylonitrile intoxications. International Archives of Occupational and Environmental Health 53: 311–319, 1984PubMedCrossRefGoogle Scholar
  6. Buckpitt AR, Warren DL. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.Journal of Pharmacology and Experimental Therapeutics 225: 8–16, 1983PubMedGoogle Scholar
  7. Bus JS, Cagen SZ, Olgaard M, Gibson JE. A mechanism of paraquat toxicity in mice and rats. Toxicology and Applied Pharmacology 35: 501–513, 1976PubMedCrossRefGoogle Scholar
  8. Byer AJ, Traylor TR, Semmer JR. Acetaminophen overdose in the third trimester of pregnancy. Journal of the American Medical Association 247: 3114–3115, 1982PubMedCrossRefGoogle Scholar
  9. Corcoran GB, Racz WJ, Smith CV, Mitchell JR. Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. Journal of Pharmacology and Experimental Therapeutics 232: 864–872, 1985PubMedGoogle Scholar
  10. Cox PJ. Cyclophosphamide cystitis: identification of acrolein as the causative agent. Biochemical Pharmacology 28: 2045–2049, 1979PubMedCrossRefGoogle Scholar
  11. Crome P, Vale JA, Volans GN, Widdop B, Goulding R. Oral methionine in the treatment of severe paracetamol (acetaminophen) poisoning. Lancet ii: 829–830, 1976CrossRefGoogle Scholar
  12. Dawson JR, Norbeck K, Anundi I, Moldeus P. The effectiveness of N-acetylcysteine in isolated hepatocytes, against the toxicity of paracetamol, acrolein, and paraquat. Archives of Toxicology 55: 11–15, 1984PubMedCrossRefGoogle Scholar
  13. De Ferreyra EC, Castro JA, Diaz Gomez MI, D’Acosta N, De Castro CR, et al. Prevention and treatment of carbon tetrachloride hepatotoxicity by cysteine: studies about its mechanism. Toxicology and Applied Pharmacology 27: 558–568, 1974PubMedCrossRefGoogle Scholar
  14. De Ferreyra EC, De Fenos OM, Bernacchi AS, De Castro CR, Castro JA. Treatment of carbon tetrachloride-induced liver necrosis with chemical compounds. Toxicology and Applied Pharmacology 42: 513–521, 1977PubMedCrossRefGoogle Scholar
  15. Editorial. Death after N-acetylcysteine. Lancet 1: 1421, 1984Google Scholar
  16. Flanagan RJ, Mant TGK. Coma and metabolic acidosis early in severe acute paracetamol poisoning. Human Toxicology 5: 179–182, 1986PubMedGoogle Scholar
  17. Floersheim GL. Treatment of human amatoxin mushroom poisoning: myths and advances in therapy. Medical Toxicology 2: 1–9, 1987PubMedCrossRefGoogle Scholar
  18. Glynn JP, Kendal SE. Paracetamol measurement. Lancet 1: 1147, 1975PubMedCrossRefGoogle Scholar
  19. Gurtoo HL, Marinello AJ, Berrigan MJ, Bansal SK, Paul B, et al. Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide. Seminars in Oncology 10 (Suppl. 1): 35–45, 1983PubMedGoogle Scholar
  20. Gut I, Nerudova J, Kopecky J, Holecek V. Acrylonitrile biotransformation in rats, mice and Chinese hamsters as influenced by the route of administration and by phenobarbital, SKF 525-A, cysteine, dimercaprol and thiosulphate. Archives of Toxicology 33: 151–161, 1975PubMedCrossRefGoogle Scholar
  21. Harvey FD, Levitt TE. Experimental evaluation of paracetamol antidotes. Journal of International Medical Research 4: 130–137, 1976PubMedGoogle Scholar
  22. Henderson P, Hale TW, Shum S, Habersang RW. N-Acetylcysteine therapy of acute heavy metal poisoning in mice. Veterinary and Human Toxicology 27: 522–525, 1985PubMedGoogle Scholar
  23. Holloway CJ, Brunner G, Schmidt E, Schmidt FW. Thiols and hepatic coma. Artificial Organs 3: 15–19, 1979PubMedCrossRefGoogle Scholar
  24. Jee RC, Sipes IG, Gandolfi AJ, Brown BR. Factors influencing halothane hepatotoxicity in the rat hypoxic model. Toxicology and Applied Pharmacology 52: 267–277, 1980PubMedCrossRefGoogle Scholar
  25. Kaplowitz N, Aw TY, Ookhtens M. The regulation of hepatic glutathione. Annual Review of Pharmacology and Toxicology 25: 715–744, 1985PubMedCrossRefGoogle Scholar
  26. Leih-Lai MW, Sarnaik AP, Newton JF, Miceli JN, Fleischmann LE, et al. Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. Journal of Pediatrics 105: 125–128, 1984CrossRefGoogle Scholar
  27. Lin JH, Levy G. Sulfate depletion after acetaminophen administration and replenishment by infusion of sodium sulfate or N-acetylcysteine in rats. Biochemical Pharmacology 30: 2723–2725, 1981PubMedCrossRefGoogle Scholar
  28. Lorber A, Baumgartner WA, Bovy RA, Chang CC, Hollcraft R. Clinical application for heavy metal complexing potential for N-acetylcysteine. Journal of Clinical Pharmacology 13: 332–336, 1973PubMedGoogle Scholar
  29. Lund ME, Banner W, Clarkson TW, Berlin M. Treatment of acute methylmercury ingestion by hemodialysis with N-acetylcysteine (Mucomyst) infusion and 2,3-dimercaptopropane sulphonate. Clinical Toxicology 22: 31–49, 1984PubMedCrossRefGoogle Scholar
  30. McLean AEM. Prevention of paracetamol poisoning. Lancet i: 729, 1974CrossRefGoogle Scholar
  31. Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine and effects of overdose. British Medical Journal 289: 217–219, 1984PubMedCrossRefGoogle Scholar
  32. Mathieson PW, Williams G, MacSweeney JE. Survival after massive ingestion of carbon tetrachloride treated by intravenous infusion of acetylcysteine. Human Toxicology 4: 627–631, 1985PubMedCrossRefGoogle Scholar
  33. McLaughlin M, Krivanek ND, Trochimowicz HJ. Evaluation of antidotes for acrylonitrile poisoning. Toxicology and Applied Pharmacology 37: 133–134, 1976Google Scholar
  34. Meister A, Anderson ME. Glutathione. Annual Review of Biochemisty 52: 711–760, 1983CrossRefGoogle Scholar
  35. Miller LF, Rumack BH. Clinical safety of high oral doses of acettylcysteine. Seminars in Oncology 10 (Suppl. 1): 76–85, 1983PubMedGoogle Scholar
  36. Miners JO, Drew R, Birkett DJ. Mechanism of action of paracetamol protective agents in mice in vivo.Biochemical Pharmacology 33: 2995–3000, 1984PubMedCrossRefGoogle Scholar
  37. Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clinical Pharmacology and Therapeutics 16: 676–684, 1974PubMedGoogle Scholar
  38. Moore M, Thor H, Moore G, Nelson S, Moldeus P, et al. The toxicity of acetaminophen and N-acetyl-p-benzoquinoneimine (NAPQI) in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. Journal of Biological Chemistry 260: 13035–13040, 1985PubMedGoogle Scholar
  39. Morgan LR, Donley PJ, Harrison EF, Hunter HL. The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lung. Seminars in Oncology 9 (Suppl. 1): 71–74, 1982PubMedGoogle Scholar
  40. Patterson CE, Butler JA, Byrne FD, Rhodes ML. Oxidant lung injury: intervention with sulphydryl reagents. Lung 163: 23–32. 1985PubMedCrossRefGoogle Scholar
  41. Piperno E, Berssenbruegge DA. Reversal of experimental paracetamol toxicosis with N-acetylcysteine. Lancet 2: 738–739, 1976PubMedCrossRefGoogle Scholar
  42. Piperno E, Mosher AH, Berssenbruegge DA, Winkler JD, Smith RB. Pathophysiology of acetaminophen overdosage toxicity: implications for management. Pediatrics 62 (Suppl. Part 2): 880–889, 1978PubMedGoogle Scholar
  43. Pohl LR, Bhooshan B, Whittaker NF, Krishna G. Phosgene: a metabolite of chloroform. Biochemical and Biophysical Research Communications 79: 684–691, 1977PubMedCrossRefGoogle Scholar
  44. Pohl LR, Branchflower RV, Highet RJ, Martin JL, Nunn DS, et al. The formation of diglutathionyl dithiocarbonate as a metabolite of chloroform, bromotrichloromethane, and carbon tetrachloride. Drug Metabolism and Disposition 9: 334–339, 1981PubMedGoogle Scholar
  45. Prescott LF. Paracetamol overdose: pharmacological considerations and clinical management. Drugs 25: 290–314, 1983PubMedCrossRefGoogle Scholar
  46. Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, et al. Intravenous N-acetylcysteine: treatment of choice for paracetamol poisoning. British Medical Journal 2: 1097–1100, 1979PubMedCrossRefGoogle Scholar
  47. Prescott LF, Matthew H. Cysteamine for paracetamol overdosage. Lancet i: 998, 1974CrossRefGoogle Scholar
  48. Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet 2: 432–434, 1977PubMedCrossRefGoogle Scholar
  49. Prescott LF, Proudfoot AT, Cregeen RJ. Paracetamol-induced acute renal failure in the absence of fulminant liver damage. British Medical Journal 284: 421–422, 1982PubMedCrossRefGoogle Scholar
  50. Read RB, Tredger JM, Williams R. Analysis of factors responsible for continuing mortality after paracetamol overdose. Human Toxicology 5: 201–206, 1986PubMedGoogle Scholar
  51. Renzi FP, Donovan JW, Martin TG, Morgan L, Harrison EF. Concomitant use of activated charcoal and N-acetylcysteine. Annals of Emergency Medicine 14: 568–572, 1985PubMedCrossRefGoogle Scholar
  52. Reynolds ES, Treinen RJ, Farrish HH, Moslen MT. Relationships between the pharmacokinetics of carbon tetrachloride conversion to carbon dioxide and chloroform and liver injury. Archives of Toxicology (Suppl. 7): 303–306, 1984Google Scholar
  53. Rumack BH. Acetaminophen overdose. American Journal of Medicine 75 (Suppl. 5A): 104–112, 1983PubMedCrossRefGoogle Scholar
  54. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Archives of Internal Medicine 141: 380–385, 1981PubMedCrossRefGoogle Scholar
  55. Ruprah M, Mant TGK, Flanagan RJ. Acute carbon tetrachloride poisoning in 19 patients: implications for diagnosis and treatment. Lancet 1: 1027–1029, 1985PubMedCrossRefGoogle Scholar
  56. Saez G, Thornalley PJ, Hill HAD, Hems R, Bannister JV. The production of free radicals during the autoxidation of cysteine and their effect of isolated rat hepatocytes. Biochimica et Biophysica Acta 719: 24–31, 1982PubMedCrossRefGoogle Scholar
  57. Shum S, Hale TW, Habersang R. Reduction of paraquat toxicity by N-acetyl-L-cysteine. Veterinary and Human Toxicology 24 (Suppl.): 158–160, 1982Google Scholar
  58. Slavik M, Saiers JH. Phase I clinical study of acetylcysteine’s preventing ifosfamide-induced hematuria. Seminars in Oncology 10 (Suppl. 1): 62–65, 1983PubMedGoogle Scholar
  59. Stewart MJ, Adriaenssens PI, Jarvie DR, Prescott LF. Inappropriate methods for the emergency determination of plasma paracetamol. Annals of Clinical Biochemistry 16: 89–95, 1979PubMedGoogle Scholar
  60. Tee LBG, Boobis AR, Huggett AC, Davies DS. Reversal of acetaminophen toxicity in isolated hamster hepatocytes by dithiothreitol. Toxicology and Applied Pharmacology 83: 294–314, 1986PubMedCrossRefGoogle Scholar
  61. Tenenbein M. Hypersensitivity-like reactions to N-acetylcysteine. Veterinary and Human Toxicology 26: 3–5, 1984PubMedGoogle Scholar
  62. Thor H, Moldeus P, Orrenius S. Effect of cysteine, N-acetylcysteine and methionine on glutathione biosynthesis and bromobenzene toxicity in isolated rat hepatocytes. Archives of Biochemistry and Biophysics 192: 405–413, 1979PubMedCrossRefGoogle Scholar
  63. Unverferth DV, Mehegan JP, Nelson RW, Scott CC, Leier CV, et al. The efficacy of N-acetylcysteine in preventing doxorubicin-induced cardiomyopathy in dogs. Seminars in Oncology 10 (Suppl. 1): 2–6, 1983PubMedGoogle Scholar
  64. Vale JA, Meredith TJ, Goulding R. Treatment of acetaminophen poisoning: the use of oral methionine. Archives of Internal Medicine 141: 394–396, 1981PubMedCrossRefGoogle Scholar
  65. Van Bladeren PJ, Breimer DD, Rotteveel-Smijs GMT, de Jong RAW, Buijs W, et al. The role of glutathione conjugation in the mutagenicity of 1,2-dibromoethane. Biochemical Pharmacology 29: 2975–2982, 1980PubMedCrossRefGoogle Scholar
  66. Vina J, Romero FJ, Estrela JM, Vina JR. Effect of acetaminophen (paracetamol) and its antagonists on glutathione (GSH) content in rat liver. Biochemical Pharmacology 29: 1968–1970, 1980PubMedCrossRefGoogle Scholar
  67. Vina J, Saez GT, Wiggins D, Roberts AFC, Hems R, et al. The effect of cysteine oxidation on isolated hepatocytes. Biochemical Journal 212: 39–44, 1983PubMedGoogle Scholar

Copyright information

© ADIS Press Limited 1987

Authors and Affiliations

  • R. J. Flanagan
    • 1
  1. 1.Poisons UnitGuy’s HospitalLondonUK
  2. 2.Poisons UnitNew Cross HospitalLondonEngland

Personalised recommendations